Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder

| April 1, 2018 | 0 Comments

by Steven D. Targum, MD; Christopher Murphy, PhD; Jibran Khan, BA; Laura Zumpano, BA; Mark Whitlock, PhD; Arthur A. Simen, MD, PhD; and Brendon Binneman, MD 

Drs. Targum and Murphy are with Bracket Global LLC in Boston, Massachusetts. Dr. Khan was with Bracket Global LLC in Boston, Massachusetts, at the time of this study. Ms. Zumpano is with Pfizer Inc. in New York, United States, and Dr. Whitlock is with Pfizer Inc. in Cambridge, United Kingdom. Dr. Simen was with Pfizer Inc. at the time of the study but is now with Takeda Pharmaceuticals in Cambridge, Massachusetts. Dr. Binneman was with Pfizer Inc. in Cambridge, Massachusetts, at the time of this study (†deceased).

Innov Clin Neurosci. 2018;15(3–4):37–42

Funding: Pfizer sponsored this study. Support for this study came from the sponsor Pfizer (Cambridge, Massachusetts) to conduct quality assurance in a clinical trial with additional support for the data analysis from Bracket Global LLC and Clintara LLC (Boston, Massachusetts).

Disclosures: Dr. Targum is an employee of Bracket LLC and has received vendor grants, retainers, or honoraria from Acadia Pharmaceuticals, Alkermes Inc., Functional Neuromodulation Inc., Intracellular Therapeutics, Janssen Research & Development, LLC, Karuna, Methylation Sciences Inc., Navitor Pharmaceuticals, Neurim Pharmaceuticals, Pfizer Inc., Prana Biotechnology Ltd., Resilience Therapeutics, and Sunovion. Dr. Murphy is an employee and Mr. Khan was an employee of Bracket Global LLC at the time of this study and have no other disclosures. Drs. Binneman and Simen, Mr. Whitlock, and Ms. Zumpano are employees of Pfizer Inc. and have no other disclosures relevant to the content of this article.

Abstract: Objective. The assessment of patients with generalized anxiety disorder (GAD) to deteremine whether a medication intervention is necessary is not always clear and might benefit from a second opinion. However, second opinions are time consuming, expensive, and not practical in most settings. We obtained independent, second opinion reviews of the primary clinician’s assessment via audio-digital recording.


The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , ,

Category: Original Research, Past Articles

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.